ストックスクリーナーアプリを入手
5.36
8.84%
-0.52
前日終値:
$5.88
開ける：
$5.81
24時間の取引高:
132.11K
Relative Volume:
0.05
時価総額：
$7.14M
収益：
-
当期純損益:
$-5.73M
株価収益率:
-0.8183
EPS:
-6.55
ネットキャッシュフロー:
$-4.13M
1週間 パフォーマンス:
-12.56%
1か月 パフォーマンス:
+70.16%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$5.23
$6.25
1週間の範囲:
$5.23
$6.37
52週間の値動き範囲:
$1.62
$29.28
Dogwood Therapeutics Inc Stock (DWTX) Company Profile
名前
Dogwood Therapeutics Inc
セクター
電話
(866) 620-8655
住所
44 MILTON AVENUE, ALPHARETTA
DWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DWTX
Dogwood Therapeutics Inc
|
5.36 | 7.14M | 0 | -5.73M | -4.13M | -6.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Dogwood Therapeutics Inc (DWTX) 最新ニュース
DWTX Stock Hits 52-Week High at $15.74 Amidst Strong Yearly Growth - MSN
Closing Figures Unveiled: Dogwood Therapeutics Inc (DWTX) Gain 13.53, Closes at 14.18 - The Dwinnex
Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Surge - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Stock market news: Planet Image International +132.83%, Akero Therapeutics +94.04% among top gainers during mid day trading - Business Upturn
Stock market news: Planet Image International surged by 160.47% while Allakos is still declining by 80.30% during mid day trading - Business Upturn
Dogwood Therapeutics : Corporate Presentation (DWTX Inc. Corporate Overview Q1 2025) - Marketscreener.com
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Su - Asianet Newsable
Clinical trial published in Nature Medicine shows proof of concept of PAGE's Therapeutics approach - Yahoo Finance
AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders - Yahoo Finance
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia - Yahoo Finance
Is This Breakthrough the Future of Pain Management? A New Hope is Here! - Slapenas
Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - Yahoo Finance
Stock market news: Dogwood Therapeutics +551.79%, CTRL Group +93.07% among top gainers during mid day trading - Business Upturn
Stock market news: Chanson International Holdings declined by 83.97% while Dogwood Therapeutics surged by 387.32% during mid day trading - Business Upturn
Alnylam Pharmaceuticals receives a prestigious "Tell Award" for business investment in Switzerland - Yahoo Finance
Stock market today: Diginex +152.27%, Vince Holding +115.96% among top gainers in early trading session - Business Upturn
ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI - Yahoo Finance
SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy - Yahoo Finance
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Holon Health Announces App, Holon Vibe, to Bridge the Gaps in Care Between Physical, Mental, and Social Health for People with Substance Use Disorder - Yahoo Finance
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar - Yahoo Finance
Vividion Therapeutics Announces Promotion of Jean Bemis to Chief Operating Officer - Yahoo Finance
Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18 - Yahoo Finance
Capricor Therapeutics (NASDAQ:CAPR) delivers shareholders fantastic 54% CAGR over 5 years, surging 12% in the last week alone - Yahoo Finance
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Nfi Group Inc 5 Pct Debs (NFI-DB-T) QuotePress Release - The Globe and Mail
Dogwood Therapeutics Announces Patient Dosing in Phase 2b - GlobeNewswire
Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Stock market today: INNOVATE +58.99%, Channel Therapeutics +49.47% among top gainers in early trading - Business Upturn
Dogwood's Breakthrough Pain Drug Halneuron Targets $1.5B Cancer Market with Phase 2b Trial - StockTitan
6 Possible Changes Coming to Prescription Drug Costs Under Trump’s Presidency - Yahoo Finance
EXCLUSIVE: Coya Therapeutics Expands Its Pipeline With Combo Therapy For Inflammatory Diseases - Yahoo Finance
Alaya.bio Expands in situ CAR-T Therapy Collaboration with Michel Sadelain and Columbia University - Yahoo Finance
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality - Yahoo Finance
Dogwood Therapeutics Poised For Data Milestone In Chemotherapy-Induced Neuropathic Pain In 2H 2025 - RTTNews
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Here’s Why Analysts Are Bullish on TG Therapeutics, Inc. (TGTX) - Yahoo Finance
Is Amicus Therapeutics (FOLD) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Yahoo Finance
Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference - Yahoo Finance
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance
Merck & Co., Inc. (MRK): A Bull Case Theory - Yahoo Finance
Why Intra-Cellular Therapies, Inc. (ITCI) Dominated Last Week’s Rally - Yahoo Finance
Dogwood Therapeutics Faces Potential Asset Loss and Financial Risks Amid Sealbond Repurchase Option - MSN
Virios Therapeutics : Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia - Marketscreener.com
Dogwood Therapeutics Inc (DWTX) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):